pFad - Phone/Frame/Anonymizer/Declutterfier! Saves Data!


--- a PPN by Garber Painting Akron. With Image Size Reduction included!

URL: http://sr.wikipedia.org/wiki/EGIS-7625

".\t,"],"wgDigitTransformTable":["",""], "wgDefaultDateFormat":"hh:mm d. month y.","wgMonthNames":["","јануар","фебруар","март","април","мај","јун","јул","август","септембар","октобар","новембар","децембар"],"wgRequestId":"b2579070-091e-4294-95a8-ed71d37ab895","wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"EGIS-7625","wgTitle":"EGIS-7625","wgCurRevisionId":28298706,"wgRevisionId":28298706,"wgArticleId":4446845,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Википројект фармаколошки чланци","5-ХТ2 антагонисти","Анилини","Пиперазини"],"wgPageViewLanguage":"sr","wgPageContentLanguage":"sr","wgPageContentModel":"wikitext","wgRelevantPageName":"EGIS-7625","wgRelevantArticleId":4446845,"wgUserVariant":"sr","wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit" :[],"wgRestrictionMove":[],"wgNoticeProject":"wikipedia","wgCiteReferencePreviewsActive":false,"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsFlags":6,"wgVisualEditor":{"pageLanguageCode":"sr","pageLanguageDir":"ltr","pageVariantFallbacks":"sr-ec"},"wgMFDisplayWikibaseDescriptions":{"search":true,"watchlist":true,"tagline":true,"nearby":true},"wgWMESchemaEditAttemptStepOversample":false,"wgWMEPageLength":2000,"wgULSCurrentAutonym":"српски / srpski","wgRelatedArticlesCompat":[],"wgCentralAuthMobileDomain":false,"wgEditSubmitButtonLabelPublish":true,"wgULSPosition":"interlanguage","wgULSisCompactLinksEnabled":false,"wgVector2022LanguageInHeader":true,"wgULSisLanguageSelectorEmpty":false,"wgWikibaseItemId":"Q5323043","wgCheckUserClientHintsHeadersJsApi":["architecture","bitness","brands","fullVersionList","mobile","model","platform","platformVersion"],"GEHomepageSuggestedEditsEnableTopics":true,"wgGETopicsMatchModeEnabled":false, "wgGEStructuredTaskRejectionReasonTextInputEnabled":false,"wgGELevelingUpEnabledForUser":false,"wgSiteNoticeId":"2.24"};RLSTATE={"ext.globalCssJs.user.styles":"ready","site.styles":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.vector.search.codex.styles":"ready","skins.vector.styles":"ready","skins.vector.icons":"ready","jquery.makeCollapsible.styles":"ready","ext.wikimediamessages.styles":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.uls.interlanguage":"ready","wikibase.client.init":"ready","ext.wikimediaBadges":"ready","ext.dismissableSiteNotice.styles":"ready"};RLPAGEMODULES=["ext.cite.ux-enhancements","site","mediawiki.page.ready","jquery.makeCollapsible","skins.vector.js","ext.centralNotice.geoIP","ext.centralNotice.startUp","ext.gadget.ReferenceTooltips","ext.urlShortener.toolbar","ext.centralauth.centralautologin","mmv.head","mmv.bootstrap.autostart","ext.popups", "ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.echo.centralauth","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.uls.interface","ext.cx.eventlogging.campaigns","ext.cx.uls.quick.actions","wikibase.client.vector-2022","ext.checkUser.clientHints","ext.growthExperiments.SuggestedEditSession","wikibase.sidebar.tracking","ext.dismissableSiteNotice"]; Пређи на садржај

EGIS-7625

С Википедије, слободне енциклопедије
EGIS-7625
IUPAC име
5-(4-Benzilpiperazin-1-il)-2-metil-4-nitroanilin
Правни статус
Правни статус
  • UN: Unscheduled
Идентификатори
CAS број755040-97-2
ATC кодnone
PubChemCID 9930789
ChemSpider8106420
UNIIVVM6OT854G ДаY
Хемијски подаци
ФормулаC18H22N4O2
Моларна маса326,40 g·mol−1
  • CC1=CC(=C(C=C1N)N2CCN(CC2)CC3=CC=CC=C3)[N+](=O)[O-]
  • InChI=1S/C18H22N4O2/c1-14-11-18(22(23)24)17(12-16(14)19)21-9-7-20(8-10-21)13-15-5-3-2-4-6-15/h2-6,11-12H,7-10,13,19H2,1H3
  • Key:ZEFXWOMFCPRXJW-UHFFFAOYSA-N

EGIS-7625 je selektivni i kompetitivni antagonist 5-HT2B receptora. Eksperimentalno je dokazano da je direktno povezan sa stezanjem mišića glatkog stomaka kod belih pacova in vivo, i promenljivo efikasan u izazivanju sličnog odgovora u in vitro ljudskim stomačnim ćelijama. U visokim koncentracijama u krvi izaziva blagu konstrikciju plućnih arterija kunića.[1]

  1. ^ Kovács A, Gacsályi I, Wellmann J, Schmidt E, Szücs Z, Dubreuil V, et al. (2003). „Effects of EGIS-7625, a selective and competitive 5-HT2B receptor antagonist”. Cardiovascular Drugs and Therapy. 17 (5–6): 427—34. PMID 15107597. S2CID 11532969. doi:10.1023/B:CARD.0000015857.96371.43. 
pFad - Phonifier reborn

Pfad - The Proxy pFad © 2024 Your Company Name. All rights reserved.





Check this box to remove all script contents from the fetched content.



Check this box to remove all images from the fetched content.


Check this box to remove all CSS styles from the fetched content.


Check this box to keep images inefficiently compressed and original size.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy